- Home
- MDXH vs PGZ Comparison
MDXH vs PGZ Comparison
Compare MDXH & PGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- PGZ
- Stock Information
- Founded
- MDXH 2003
- PGZ 2012
- Country
- MDXH Belgium
- PGZ United States
- Employees
- MDXH N/A
- PGZ N/A
- Industry
- MDXH
- PGZ Investment Managers
- Sector
- MDXH
- PGZ Finance
- Exchange
- MDXH Nasdaq
- PGZ Nasdaq
- Market Cap
- MDXH 84.6M
- PGZ 69.3M
- IPO Year
- MDXH 2021
- PGZ N/A
- Fundamental
- Price
- MDXH $2.09
- PGZ $10.23
- Analyst Decision
- MDXH Buy
- PGZ
- Analyst Count
- MDXH 1
- PGZ 0
- Target Price
- MDXH $6.00
- PGZ N/A
- AVG Volume (30 Days)
- MDXH 75.5K
- PGZ 23.0K
- Earning Date
- MDXH 05-14-2025
- PGZ 01-01-0001
- Dividend Yield
- MDXH N/A
- PGZ 12.26%
- EPS Growth
- MDXH N/A
- PGZ N/A
- EPS
- MDXH N/A
- PGZ N/A
- Revenue
- MDXH $94,507,000.00
- PGZ N/A
- Revenue This Year
- MDXH $23.38
- PGZ N/A
- Revenue Next Year
- MDXH $16.84
- PGZ N/A
- P/E Ratio
- MDXH N/A
- PGZ N/A
- Revenue Growth
- MDXH 25.46
- PGZ N/A
- 52 Week Low
- MDXH $1.35
- PGZ $8.46
- 52 Week High
- MDXH $3.50
- PGZ $10.59
- Technical
- Relative Strength Index (RSI)
- MDXH 74.52
- PGZ 49.00
- Support Level
- MDXH $1.67
- PGZ $10.13
- Resistance Level
- MDXH $1.99
- PGZ $10.40
- Average True Range (ATR)
- MDXH 0.13
- PGZ 0.15
- MACD
- MDXH 0.02
- PGZ -0.01
- Stochastic Oscillator
- MDXH 97.67
- PGZ 18.18
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About PGZ Principal Real Estate Income Fund of Beneficial Interest
Principal Real Estate Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to provide high current income with capital appreciation by investing in commercial real estate-related securities. The company does its investments in USA, Australia, Japan, France, Great Britain, Canada, Hong Kong, Germany, Singapore, South Korea, British Virgin Islands and more.